...血酶活纤溶抑制物 纤维蛋白溶解 血浆数基肽酶原B 【文 摘】凝血酶激活纤溶抑制物(thrombin activated fibrinolysis inhibitor，TAFI)是近年来发现存在于血浆中的一种蛋白酶原，属于数肽酶家族成员。
基于4个网页-相关网页
...以提供外在的在分子水平连接凝血与纤溶系统的血浆酶原-凝血酶激活的纤溶抑制物(thrombin-activated fibrinolysis inhibitor,TAFI)是近几年来国内外研究的热点.
基于2个网页-相关网页
的纤溶抑制物 thrombin-activatable fibrinolysis Inhibitor
凝血酶激活纤溶抑制物 TAFI ; thrombin-activatable fibrinolysis inhibitor ; thrombin activated fibrindlysisinhibitor
激活纤溶抑制物 thrombin activatable fibrinolysis inhibitor ; TAFI
凝血酶活化纤溶抑制物 thrombin-activatable fibrinolysis inhibitor
纤溶酶抑制物 plasmin inhibitor
纤溶酶原抑制物 Plasma plasminogen inhibitor
组织纤溶酶原抑制物 Plasminogenemia Activator Inhibitor
纤溶酶原激活抑制物 plasminogen activator inhibitor
目的探讨纤溶酶原激活物抑制物- 1（ PAI- 1）启动子区基因多态性与脑卒中的关系。
Objective To investigate the relationship between the plasminogen activator inhibitor 1(PAI 1) promotor region gene polymorphism and cerebral stroke.
用酶联免疫吸附法检测血浆血管性假性血友病因子、凝血酶调节蛋白、纤溶酶原激活物抑制物1水平。
The von Willebrand's disease factors in plasm, adjusted protein of thrombase and inhibitor 1 of activator of plasminogen were detected with enzyme-linked immunosorbent assay.
目的：观察银杏叶提取物对2型糖尿病病人纤溶酶原激活物抑制物1（PAI 1）及凝血烷B2（TXB 2 ）的影响。
AIM: To observe the effect of extract of Ginkgo biloba leaves on plasminogen activator inhibitor 1(PAI-1)and thromboxane B2(TXB-2)in type 2 diabetes mellitus(DM).
应用推荐